Moody Aldrich Partners LLC Axsome Therapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

$475 Million
Q4 2024

A detailed history of Moody Aldrich Partners LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 45,138 shares of AXSM stock, worth $4.65 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

45,138

Previous 60,644 25.57%

Holding current value

$4.65 Million

Previous $5.45 Million 29.9%

% of portfolio

0.8%

Previous 1.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$83.08 - $100.49 $1.29 Million - $1.56 Million	-15,506 Reduced 25.57%	45,138 $3.82 Million
Q3 2024 Oct 22, 2024	SELL	$78.93 - $95.84 $87,375 - $106,094	-1,107 Reduced 1.79%	60,644 $5.45 Million
Q2 2024 Jul 23, 2024	SELL	$65.72 - $80.5 $256,833 - $314,594	-3,908 Reduced 5.95%	61,751 $4.97 Million
Q1 2024 Apr 29, 2024	SELL	$69.39 - $97.64 $83,753 - $117,851	-1,207 Reduced 1.81%	65,659 $5.24 Million
Q4 2023 Jan 25, 2024	SELL	$57.42 - $83.61 $388,561 - $565,788	-6,767 Reduced 9.19%	66,866 $5.32 Million
Q3 2023 Nov 07, 2023	BUY	$69.25 - $82.21 $619,095 - $734,957	8,940 Added 13.82%	73,633 $5.15 Million
Q2 2023 Jul 28, 2023	BUY	$58.41 - $90.35 $1.88 Million - $2.9 Million	32,114 Added 98.57%	64,693 $4.65 Million
Q1 2023 Apr 27, 2023	SELL	$58.39 - $75.0 $1.14 Million - $1.47 Million	-19,567 Reduced 37.52%	32,579 $2.01 Million
Q4 2022 Jan 23, 2023	SELL	$39.94 - $79.72 $2.8 Million - $5.59 Million	-70,115 Reduced 57.35%	52,146 $0
Q3 2022 Oct 18, 2022	BUY	$36.06 - $69.85 $2.87 Million - $5.57 Million	79,721 Added 187.4%	122,261 $5.46 Million
Q2 2022 Jul 18, 2022	BUY	$21.74 - $46.75 $924,819 - $1.99 Million	42,540 New	42,540 $1.63 Million
Q1 2022 May 10, 2022	SELL	$23.7 - $41.39 $1.02 Million - $1.77 Million	-42,871 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$30.7 - $43.36 $246,306 - $347,877	-8,023 Reduced 15.76%	42,871 $1.62 Million
Q3 2021 Oct 29, 2021	BUY	$19.91 - $68.26 $137,657 - $471,949	6,914 Added 15.72%	50,894 $1.68 Million
Q2 2021 Aug 04, 2021	SELL	$50.63 - $73.5 $29,618 - $42,997	-585 Reduced 1.31%	43,980 $2.97 Million
Q1 2021 May 10, 2021	BUY	$55.91 - $81.44 $53,226 - $77,530	952 Added 2.18%	44,565 $2.52 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $4,973 - $6,489	-75 Reduced 0.17%	43,613 $3.55 Million
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $923,410 - $1.16 Million	13,512 Added 44.78%	43,688 $3.11 Million
Q2 2020 Jul 30, 2020	SELL	$49.87 - $98.69 $1.6 Million - $3.16 Million	-32,030 Reduced 51.49%	30,176 $2.48 Million
Q1 2020 May 07, 2020	BUY	$41.2 - $101.31 $700 - $1,722	17 Added 0.03%	62,206 $3.66 Million
Q4 2019 Feb 07, 2020	SELL	$16.71 - $106.24 $182,072 - $1.16 Million	-10,896 Reduced 14.91%	62,189 $6.43 Million
Q3 2019 Nov 12, 2019	BUY	$20.24 - $29.16 $30,562 - $44,031	1,510 Added 2.11%	73,085 $1.48 Million
Q2 2019 Jul 26, 2019	BUY	$13.46 - $25.75 $963,399 - $1.84 Million	71,575 New	71,575 $1.84 Million

Others Institutions Holding AXSM

# of Institutions

328

Shares Held

37.8M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.42B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Account

Moody Aldrich Partners LLC Axsome Therapeutics, Inc. Transaction History